1. Home
  2. IBM vs NVS Comparison

IBM vs NVS Comparison

Compare IBM & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBM
  • NVS
  • Stock Information
  • Founded
  • IBM 1911
  • NVS 1895
  • Country
  • IBM United States
  • NVS Switzerland
  • Employees
  • IBM N/A
  • NVS N/A
  • Industry
  • IBM Computer Manufacturing
  • NVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • IBM Technology
  • NVS Health Care
  • Exchange
  • IBM Nasdaq
  • NVS Nasdaq
  • Market Cap
  • IBM 249.5B
  • NVS 230.5B
  • IPO Year
  • IBM N/A
  • NVS 1991
  • Fundamental
  • Price
  • IBM $258.80
  • NVS $115.75
  • Analyst Decision
  • IBM Buy
  • NVS Hold
  • Analyst Count
  • IBM 14
  • NVS 6
  • Target Price
  • IBM $254.86
  • NVS $123.67
  • AVG Volume (30 Days)
  • IBM 3.7M
  • NVS 1.7M
  • Earning Date
  • IBM 07-23-2025
  • NVS 07-17-2025
  • Dividend Yield
  • IBM 2.59%
  • NVS 3.45%
  • EPS Growth
  • IBM N/A
  • NVS N/A
  • EPS
  • IBM 5.83
  • NVS 6.38
  • Revenue
  • IBM $62,832,000,000.00
  • NVS $53,222,000,000.00
  • Revenue This Year
  • IBM $6.42
  • NVS $7.22
  • Revenue Next Year
  • IBM $4.34
  • NVS $1.94
  • P/E Ratio
  • IBM $44.30
  • NVS $17.41
  • Revenue Growth
  • IBM 1.23
  • NVS 11.50
  • 52 Week Low
  • IBM $163.53
  • NVS $96.06
  • 52 Week High
  • IBM $269.28
  • NVS $120.92
  • Technical
  • Relative Strength Index (RSI)
  • IBM 54.86
  • NVS 62.89
  • Support Level
  • IBM $256.77
  • NVS $111.06
  • Resistance Level
  • IBM $265.00
  • NVS $113.91
  • Average True Range (ATR)
  • IBM 4.95
  • NVS 1.57
  • MACD
  • IBM -0.67
  • NVS 0.45
  • Stochastic Oscillator
  • IBM 57.45
  • NVS 98.99

About IBM International Business Machines Corporation

IBM looks to be a part of every aspect of an enterprise's IT needs. The company primarily sells software, IT services, consulting, and hardware. IBM operates in 175 countries and employs approximately 300,000 people. The company has a robust roster of business partners to service its clients, which include 95% of all Fortune 500 companies. Primary products include its mainframes, Red Hat software, transaction processing software, and IT consulting.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Share on Social Networks: